These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8356416)

  • 21. Alpha-interferon in the treatment of idiopathic myelofibrosis.
    List AF; Doll DC
    Br J Haematol; 1992 Apr; 80(4):566-7. PubMed ID: 1581246
    [No Abstract]   [Full Text] [Related]  

  • 22. Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis.
    Cannon GW; Pincus SH; Emkey RD; Denes A; Cohen SA; Wolfe F; Saway PA; Jaffer AM; Weaver AL; Cogen L
    Arthritis Rheum; 1989 Aug; 32(8):964-73. PubMed ID: 2504171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of essential thrombocythaemia with interferon alpha-2b.
    May D; Wandl UB; Niederle N
    Lancet; 1989 Jan; 1(8629):96. PubMed ID: 2562897
    [No Abstract]   [Full Text] [Related]  

  • 24. MM-093, a recombinant human alpha-fetoprotein for the potential treatment of rheumatoid arthritis and other autoimmune diseases.
    Dudich E
    Curr Opin Mol Ther; 2007 Dec; 9(6):603-10. PubMed ID: 18041671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemorrhagic fever with renal syndrome: treatment with recombinant alpha interferon.
    Gui XE; Ho M; Cohen MS; Wang QL; Huang HP; Xie QX
    J Infect Dis; 1987 May; 155(5):1047-51. PubMed ID: 2881968
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-interferon antibodies in alpha interferon treated patients with chronic myeloid leukaemia.
    Aitchison R; Allen P; Schey S; Newland AC
    Br J Haematol; 1991 Jul; 78(3):465-7. PubMed ID: 1873235
    [No Abstract]   [Full Text] [Related]  

  • 27. Prospective two-year followup of recombinant interferon-gamma in rheumatoid arthritis.
    Cannon GW; Emkey RD; Denes A; Cohen SA; Saway PA; Wolfe F; Jaffer AM; Weaver AL; Cogen L; Gulinello J
    J Rheumatol; 1990 Mar; 17(3):304-10. PubMed ID: 2110252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rheumatoid arthritis complicating adjuvant interferon-alpha therapy for malignant melanoma.
    Johnson DM; Hayat SQ; Burton GV
    J Rheumatol; 1999 Apr; 26(4):1009-10. PubMed ID: 10229440
    [No Abstract]   [Full Text] [Related]  

  • 29. Intralesional alpha 2b recombinant interferon for basal cell carcinomas.
    Boneschi V; Brambilla L; Chiappino G; Mozzanica N; Finzi AF
    Int J Dermatol; 1991 Mar; 30(3):220-4. PubMed ID: 2037410
    [No Abstract]   [Full Text] [Related]  

  • 30. [Phase II trial of treatment of metastatic renal adenocarcinoma with recombinant leukocyte interferon (rDNA IFN-alpha 2)].
    Dorval T; Palangie T; Garcia-Giralt E; Jouve M; Bretaudeau B; Falcoff F; Coninx P; Schwab D; Pouillart P
    Bull Cancer; 1985; 72(5):470-1. PubMed ID: 4074917
    [No Abstract]   [Full Text] [Related]  

  • 31. Production of human alpha- and gamma-interferon is dependent on age and sex and is decreased in rheumatoid arthritis: a simple method for a large-scale assay.
    Kita M; Shiozawa S; Yamaji M; Kitoh I; Kishida T
    J Clin Lab Anal; 1991; 5(4):238-41. PubMed ID: 1653827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant alpha-2a interferon in the treatment of refractory anemia with excess of blasts.
    Rossi G; Pagetto A; Boverio R; Montanaro G
    Haematologica; 1990; 75(1):97-8. PubMed ID: 2338298
    [No Abstract]   [Full Text] [Related]  

  • 33. Retreatment with recombinant interferon-alpha in patients with chronic hepatitis C.
    Marcellin P; Pouteau M; Boyer N; Castelnau C; Erlinger S; Benhamou JP
    J Infect Dis; 1993 Mar; 167(3):780-1. PubMed ID: 8440950
    [No Abstract]   [Full Text] [Related]  

  • 34. Combination recombinant interleukin-2, recombinant interferon-alpha, and 5-fluorouracil for treatment of metastatic renal cell carcinoma.
    Ueno NT; Zukiwski AA
    Am J Clin Oncol; 1995 Aug; 18(4):358-62. PubMed ID: 7625380
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of verrucae vulgaris with alpha 2 interferon.
    Berman B; Davis-Reed L; Silverstein L; Jaliman D; France D; Lebwohl M
    J Infect Dis; 1986 Aug; 154(2):328-30. PubMed ID: 3522759
    [No Abstract]   [Full Text] [Related]  

  • 36. Alpha-interferon for severe cold agglutinin disease.
    O'Connor BM; Clifford JS; Lawrence WD; Logue GL
    Ann Intern Med; 1989 Aug; 111(3):255-6. PubMed ID: 2502059
    [No Abstract]   [Full Text] [Related]  

  • 37. Lymphogranulomatosis X: complete remission by low dose interferon-alpha.
    Meuthen I; Lennert K; Siegert W
    Br J Haematol; 1990 Jul; 75(3):438-9. PubMed ID: 2386776
    [No Abstract]   [Full Text] [Related]  

  • 38. A sensitive radioimmunoassay for alpha-interferon: circulating alpha-interferon-like substance in the plasma of healthy individuals and rheumatoid arthritis patients.
    Shiozawa S; Chihara K; Shiozawa K; Fujita T; Ikegami H; Koyama S; Kurimoto M
    Clin Exp Immunol; 1986 Oct; 66(1):77-87. PubMed ID: 3802576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II trial of recombinant alpha-2b interferon in the treatment of metastatic skin melanoma.
    Sertoli MR; Bernengo MG; Ardizzoni A; Brunetti I; Falcone A; Vidili MG; Cusimano MP; Appino A; Doveil G; Fortini C
    Oncology; 1989; 46(2):96-8. PubMed ID: 2710482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of hairy cell leukaemia with recombinant alpha-interferon.
    Bezwoda WR; Hesdorffer CS; Dansey RD; Lewis D
    S Afr Med J; 1987 Nov; 72(10):661-2. PubMed ID: 3686262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.